Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

University of Toronto

$199,000.00

Digital microfluidics and digital detection for in vitro diagnostics

EF 2019-20

Résumé
The cost of delivering healthcare in Canada is increasing at an unsustainable pace. De-centralized, small-footprint in vitro diagnostic (IVD) systems, which can be implemented with significant reductions in cost, may provide some relief to this problem. The Wheeler Lab at the University of Toronto is working with international IVD market leader, Abbott Laboratories, to develop miniaturized immunoassay systems based on digital microfluidics (DMF), a technique in which sample and reagent droplets are moved across a surface by applying electrical potentials to an array of electrodes. Compared to conventional systems, the new DMF systems offer the potential for 100-fold and 10-fold reductions in reagent volumes and analysis time, respectively, while retaining a level of analytical performance required for clinical screening. The work proposed here is a continuation of an on-going collaboration between the Wheeler Lab and Abbott to further optimize the technology such that it may be commercialized. Working with a diverse team of Abbott scientists based in Ottawa, ON, Chicago, IL, and Dallas, TX, this project has the potential to significantly impact the diagnostics market in Canada and around the world.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
521715-2017
Name nom
Wheeler, Aaron
Department département
Chemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2017
Award amount
199000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3500
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical chemistry
Research subject fr
Chimie analytique
Installment
inst:2 - 2
Partie
2
Nb partie
2
Application title
Digital microfluidics and digital detection for in vitro diagnostics
Keyword
NSERC
Application summary
The cost of delivering healthcare in Canada is increasing at an unsustainable pace. De-centralized, small-footprint in vitro diagnostic (IVD) systems, which can be implemented with significant reductions in cost, may provide some relief to this problem. The Wheeler Lab at the University of Toronto is working with international IVD market leader, Abbott Laboratories, to develop miniaturized immunoassay systems based on digital microfluidics (DMF), a technique in which sample and reagent droplets are moved across a surface by applying electrical potentials to an array of electrodes. Compared to conventional systems, the new DMF systems offer the potential for 100-fold and 10-fold reductions in reagent volumes and analysis time, respectively, while retaining a level of analytical performance required for clinical screening. The work proposed here is a continuation of an on-going collaboration between the Wheeler Lab and Abbott to further optimize the technology such that it may be commercialized. Working with a diverse team of Abbott scientists based in Ottawa, ON, Chicago, IL, and Dallas, TX, this project has the potential to significantly impact the diagnostics market in Canada and around the world.